SEC Form 4 filings for LEVIN CAPITAL STRATEGIES, L.P.Levin Capital Strategies GP, LLCLevin Capital Trilogy Master Fund, Ltd.LCS, LLCLevcap Alternative Fund, L.P.LCS Event Partners, LLCSafinia Partners, L.P.LCS L/S, LLCLEVIN JOHN A,

Insider trading of Capital Strategies, L.P.Lev..., a at FLDM Fluidigm Corporation

Most recently Capital Strategies, L.P.Lev... bought 95,843 shares worth $438,002.51 on 9 October 2017.

Insider Title
Shares Price per share Total price Shares after Source
2017-10-09 FLDM Capital Strategies, L.P.Lev... Buy 95,843 $4.57 $438,002.51 10,229,617 SEC insider form 4
2017-09-12 FLDM Capital Strategies, L.P.Lev... Buy 60,000 $5.25 $315,000.00 1,161,226 SEC insider form 4
2017-08-17 FLDM Capital Strategies, L.P.Lev... Buy 465 $3.66 $1,701.90 10,122,581 SEC insider form 4
2017-08-09 FLDM Capital Strategies, L.P.Lev... Buy 1,549 $3.18 $4,925.82 6,334,209 SEC insider form 4
2016-11-03 FLDM Capital Strategies, L.P.Lev... Buy 159,200 $4.44 $706,848.00 6,343,743 SEC insider form 4
2016-11-01 FLDM Capital Strategies, L.P.Lev... Buy 48,302 $4.44 $214,460.88 6,184,543 SEC insider form 4
Fluidigm Corporation logo

Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research. It offers preparatory instruments, such as access array system, juno system, and callisto system; analytical instruments comprising biomark HD and EP1 systems; integrated fluidic circuits (IFCs) consisting of access array, juno genotyping, dynamic array, digital array, flex six, and callisto IFCs; and assays and reagents, including delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. The company also provides C1 single-cell systems, polaris systems, C1 IFCs, polaris IFCs, helios/CyTOF 2 systems, maxpar reagents, imaging mass cytometer instruments and reagents, and laser ablation modules. It serves academic institutions; clinical research laboratories; biopharmaceutical, biotechnology, and agricultural biotechnology companies; and contract research organizations. Fluidigm Corporation distributes its systems through direct sales force and support organizations located in North America, Europe, and the Asia-Pacific, and through distributors or sales agents in various European, Latin American, Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.

  • Fluidigm Corporation, 7000 Shoreline Court, South San Francisco 94080, United States
  • 650-266-6000